#PACB PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026

#PACB PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026
📄 $PACB 10-Q — what changed
MD&A now says: "Q2 Fiscal 2026 Form 10-Q 27 Table of Contents Strategic Objectives Our 2026 main objectives are to grow revenue and expand gross margins through the following five activities."
📈 Full redline → https://www.formdelta.com/ticker/PACB
#PACB PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics